Dabur At-a-Glance

• Leading consumer goods company in India with a turnover of Rs. 5,283 Crore (FY12)

• 17 ultra-modern manufacturing units spread around the globe

• Products marketed in over 60 countries

• 2 major strategic business units (SBU) - Consumer Care Business and International Business Division (IBD)

• 2 Subsidiary Group companies - Dabur International and NewU Several step down subsidiaries:

Dabur Nepal Pvt Ltd (Nepal)Dabur Egypt Ltd (Egypt)Asian Consumer Care (Bangladesh)

Asian Consumer Care (Pakistan)African Consumer Care (Nigeria)Naturelle LLC (Ras Al Khaimah-UAE)Weikfield International (UAE) Jaquline Inc. (USA)

Strategies taken for re gain and expand the market

Indian market• Decided to outsource non-core businesses like IT,

and to concentrate on making quality consumer products

• Decided to refurbish product portfolio and enter several emerging and sunrise categories such as skin care, packaged fruit juice and toothpaste

• drew up a rapid expansion plan which also included taking the inorganic route to grow business

• recognised - much ahead of the competition - that rural India would become a key growth drive

Capturing overseas market

• Entered West Asian market.• Decided to establish a manufacturing facility

abroad• That made Dabur more nimble in addressing

the changing needs of consumers, and provide us a leaner and quicker supply chain

• Today overseas market contributes nearly 30% of consolidated turnover

Strengths

• Dabur India is the fourth largest company in FMCG segment with a revenue of US$ 910 Millions

• Dabur has its own heritage, it is more than 100 years old , established in the year 1884

• It has presence in around 60 countries across the world• It is the world’s largest ayurvedic medicine provider• The product length includes around 300 prescribed products

and few of them are sold over the counter• Wide and deep market penetration with 50 C&F agents, more

than 5000 distributors and over3.4 million retail outlets all over India

Weaknesses

• Dabur doesn’t have direct company outlets• Lack of awareness of products by customers• Doctors prescribe allopathy medicines as they get more

incentives from medical companies and the share of ayurvedic companies are less compared to allopathy

• Ayurvedic medicine takes time to cure compare to allopathy medicine

Opportunities

• Dabur is the world’s largest ayurvedic medicine and its export quantities are constantly in demand in foreign market

• The affinity towards yoga is proving more advantageous towards the reach of ayurvedic medicines globally

• People have started realizing that ayurvedic medicines doesn’t have much of side effects

• Growing women’s earning power has made them independent and has made them to be more health and beauty conscious

• Ayurveda as a field is receiving much more attention across the world in the last 2–3 years. Thus huge opportunity for Dabur to capitalize on the market sentiments.

Threats

• The allopathy players are of major threat as they invest heavily on advertising and distribution of their products through medical representatives etc

• Some ayurvedic doctors give their own medicines or give a mixture of Ayurvedic Company’s product without packaging (loose medicines).

• Lead and ferric content is more present in many ayurvedic medicine, this may sometime result in reverse side effects when consumer over longer period